Empagliflozin for treating chronic kidney disease

Equality Impact Assessment (Guidance development) (PDF 143 KB)

Final draft guidance

Committee papers (PDF 10.48 MB)

Final appraisal document Equality Impact Assessment (PDF 143 KB)

Final draft guidance (PDF 142 KB)

Invitation to participate

Final scope (PDF 202 KB)

Final stakeholder list (PDF 159 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 618 KB)

Equality impact assessment (Scoping) (PDF 127 KB)

Draft matrix post referral (PDF 160 KB)

Draft scope post referral (PDF 211 KB)